Navigation Links
Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack

RANCHO MIRAGE, Calif., March 27 /PRNewswire/ -- In the medical community at large, there is no disputing the fact that heart attacks kill and destroy cells in the heart muscle. Multiple attempts by medical research scientists to figure out how to stimulate the heart to repair itself after an individual suffers a heart attack have repeatedly failed ... until now!

The Weil Institute of Critical Care Medicine, located in Rancho Mirage, California, is home to a brilliant group of medical research scientists who strive on a daily basis to provide cutting-edge breakthroughs to improve the success of preserving the life of those that suffer sudden cardiac arrest. This dynamic team, headed by world-renowned heart surgeon Dr. Wanchung Tang, sought to find the answer to rejuvenate the cells that were damaged and destroyed in the heart muscle from a heart attack. The beginning of this brilliant discovery started with the theory that by using bone marrow, the stem cells in the marrow would find their way to the heart muscle and begin to take over the function of the damaged and destroyed cells. These stem cells, in effect, would replace the dead cells and adapt themselves to become viable beating heart cells!

The Weil Institute medical investigation team has published its findings in various medical journals around the world. They have successfully been able to produce new, fully functional heart cells using the bone marrow donated from rats. The stem cells, once injected into the blood stream over a period of time, did indeed find their way to the heart and replaced the damaged cells that had been destroyed. Most importantly, these are the cells that had been destroyed due to a heart attack. New cells were effectively created and after painstaking monitoring over a period of time, it was duly found that the heart function of the subject improved significantly. To find out how you can become involved with The Weil Institute of Critical Care Medicine and partner with them to continue this lifesaving research, please visit or call 760-778-4911 today.


Max Harry Weil, MD, PhD, ScD (Hon)


This release was issued through eReleases(TM). For more information, visit

SOURCE Weil Institute of Critical Care Medicine
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
2. Velos to Develop Key System Interface for Clinical Research
3. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
4. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
5. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
6. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
7. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
8. Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention
9. Women Invited to Join New Health Registry to Advance Research
10. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
11. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
Post Your Comments:
(Date:12/1/2015)... VANCOUVER , Dec. 1, 2015  Following an ... (NASDAQ: OGXI ) announced today that its Phase ... interim futility analysis of the intent-to-treat (ITT) population. In ... identified by the DMC. Both the DMC and OncoGenex ... expected in the second half of 2016, depending on ...
(Date:12/1/2015)... , Dec. 1, 2015  CytoSorbents Corporation (NASDAQ: ... commercializing its CytoSorb® blood purification technology to reduce ... world, today announced that Dr. Phillip Chan ... to participate in the LD Micro Main Event ... Conference, both of which will be held in ...
(Date:12/1/2015)... Colo. , Dec. 1, 2015 /PRNewswire/ ... ) today announced that its Chief Executive ... at the Oppenheimer Annual Healthcare Conference in ... participate in the conference through a webcast ... , --> ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... Hospital Tampa is the first health care provider in the region to offer the ... is a vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult ... least 40 to 45 kg, or a BMI of at least 35 to 39.9 kg ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Dr. Paul Vitenas, ... Cosmetic Surgery, has been named by MedEsthetics magazine as the Best Single Physician Practice ... best among the many elite aesthetic physicians honored by the industry publication. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Annual 2015 Golden Bridge Business Awards under the New Products and Services category ... web based sample management software that helps labs organize data and ...
(Date:12/1/2015)... ... 2015 , ... For many X-rays taken at hospitals, doctors’ ... by the radiologist. The marking utensils are so small, however, they are difficult ... way to alleviate this problem. , He developed the patent-pending MARK N SHOW ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been awarded a fixed price per sprint agile development contract to support ... $34 million over five years, provides software engineering, infrastructure, as well as operations ...
Breaking Medicine News(10 mins):